Intelligence, benchmarking, and certification for risk and compliance leaders, from the institution setting the standard since 1922.
Abbott Laboratories will pay nearly $385 million to settle allegations, first brought by whistleblowers, that two of its infant formula plants had unsanitary conditions that did not comply with federal and state regulations, the U.S. Department of Justice (DOJ) announced.
Adrianne Appel writes regulatory news, policy, and trends for Compliance Week. She previously reported about policy developments for Bloomberg Law and Bloomberg Government. Email: adrianne.appel@complianceweek.com LinkedIn:... More by Adrianne Appel
We'll send a verification code to %EMAIL%.
